Cell Bio Human Tech Co.,Ltd Statistics

Total Valuation

Cell Bio Human Tech Co.,Ltd has a market cap or net worth of KRW 27.83 billion. The enterprise value is 17.70 billion.

Market Cap	27.83B
Enterprise Value	17.70B

Important Dates

The next estimated earnings date is Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

Cell Bio Human Tech Co.,Ltd has 8.82 million shares outstanding. The number of shares has increased by 23.42% in one year.

Shares Outstanding	8.82M
Shares Change (YoY)	+23.42%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	36.96%
Owned by Institutions (%)	4.20%
Float	5.10M

Valuation Ratios

The trailing PE ratio is 32.36.

PE Ratio	32.36
Forward PE	n/a
PS Ratio	1.03
PB Ratio	0.64
P/FCF Ratio	4.23
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.54, with an EV/FCF ratio of 2.69.

EV / Earnings	19.88
EV / Sales	0.64
EV / EBITDA	3.54
EV / EBIT	5.44
EV / FCF	2.69

Financial Position

The company has a current ratio of 3.24, with a Debt / Equity ratio of 0.14.

Current Ratio	3.24
Quick Ratio	2.55
Debt / Equity	0.14
Debt / EBITDA	1.24
Debt / FCF	0.94
Interest Coverage	6.99

Financial Efficiency

Return on equity (ROE) is 2.02% and return on invested capital (ROIC) is 4.01%.

Return on Equity (ROE)	2.02%
Return on Assets (ROA)	3.84%
Return on Capital (ROIC)	4.01%
Revenue Per Employee	471.80M
Profits Per Employee	15.09M
Employee Count	59
Asset Turnover	0.53
Inventory Turnover	2.46

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.52% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-19.52%
50-Day Moving Average	3,231.80
200-Day Moving Average	3,835.00
Relative Strength Index (RSI)	54.91
Average Volume (20 Days)	27,645

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cell Bio Human Tech Co.,Ltd had revenue of KRW 27.84 billion and earned 890.31 million in profits. Earnings per share was 97.50.

Revenue	27.84B
Gross Profit	8.02B
Operating Income	3.25B
Pretax Income	2.40B
Net Income	890.31M
EBITDA	4.99B
EBIT	3.25B
Earnings Per Share (EPS)	97.50

Full Income Statement

Balance Sheet

The company has 16.77 billion in cash and 6.19 billion in debt, giving a net cash position of 10.58 billion or 1,199.65 per share.

Cash & Cash Equivalents	16.77B
Total Debt	6.19B
Net Cash	10.58B
Net Cash Per Share	1,199.65
Equity (Book Value)	44.13B
Book Value Per Share	4,952.22
Working Capital	17.88B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.19 billion and capital expenditures -600.36 million, giving a free cash flow of 6.59 billion.

Operating Cash Flow	7.19B
Capital Expenditures	-600.36M
Free Cash Flow	6.59B
FCF Per Share	746.59

Full Cash Flow Statement

Margins

Gross margin is 28.81%, with operating and profit margins of 11.69% and 3.20%.

Gross Margin	28.81%
Operating Margin	11.69%
Pretax Margin	8.63%
Profit Margin	3.20%
EBITDA Margin	17.94%
EBIT Margin	11.69%
FCF Margin	23.66%

Dividends & Yields

Cell Bio Human Tech Co.,Ltd does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.42%
Shareholder Yield	-23.42%
Earnings Yield	3.09%
FCF Yield	23.66%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cell Bio Human Tech Co.,Ltd has an Altman Z-Score of 4.29.

Altman Z-Score	4.29
Piotroski F-Score	n/a